Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Chao, Shinichi Saito, Jian Kang, C. Anderson, E. Appella, Yang Xu (2000)
p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damageThe EMBO Journal, 19
Suzanne Szak, D. Mays, J. Pietenpol (2001)
Kinetics of p53 Binding to Promoter Sites In VivoMolecular and Cellular Biology, 21
DP Brazil, BA Hemmings (2001)
Ten years of protein kinase B signalling: a hard Akt to followTrends Bio. Chem. Sci., 26
K. Oda, H. Arakawa, Tomoaki Tanaka, K. Matsuda, C. Tanikawa, Toshiki Mori, H. Nishimori, K. Tamai, T. Tokino, Yusuke Nakamura, Y. Taya (2000)
p53AIP1, a Potential Mediator of p53-Dependent Apoptosis, and Its Regulation by Ser-46-Phosphorylated p53Cell, 102
P. Friedlander, Y. Haupt, C. Prives, M. Oren (1996)
A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosisMolecular and Cellular Biology, 16
G. Rozenfeld-Granot, J. Krishnamurthy, K. Kannan, A. Toren, N. Amariglio, D. Givol, G. Rechavi (2002)
A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1Oncogene, 21
T. Gottlieb, J. Leal, R. Seger, Y. Taya, M. Oren (2002)
Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosisOncogene, 21
Kevin Ryan, K. Vousden (1998)
Characterization of Structural p53 Mutants Which Show Selective Defects in Apoptosis but Not Cell Cycle ArrestMolecular and Cellular Biology, 18
N. Dumaz, D. Meek (1999)
Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2The EMBO Journal, 18
M. Bennett, K. Macdonald, S. Chan, J. Luzio, R. Simari, P. Weissberg (1998)
Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis.Science, 282 5387
E Sadot, B Geiger, M Oren, A Ben-Ze'ev (2001)
Downregulation of beta-catenin by activated p53Mol. Cell Biol., 21
C. Schmitt, J. Fridman, Meng Yang, E. Baranov, R. Hoffman, S. Lowe (2002)
Dissecting p53 tumor suppressor functions in vivo.Cancer cell, 1 3
Li Fang, Guangnan Li, Guizhong Liu, Sam Lee, Stuart Aaronson (2001)
p53 induction of heparin‐binding EGF‐like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascadesThe EMBO Journal, 20
G. Jimenez, M. Nistér, J. Stommel, M. Beeche, E. Barcarse, Xiao-qun Zhang, S. O’Gorman, G. Wahl (2000)
A transactivation-deficient mouse model provides insights into Trp53 regulation and functionNature Genetics, 26
K. Nicholson, N. Anderson (2002)
The protein kinase B/Akt signalling pathway in human malignancy.Cellular signalling, 14 5
M. Kaeser, R. Iggo (2001)
Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivoProceedings of the National Academy of Sciences of the United States of America, 99
H. Brantjes, Nick Barker, Johan Es, Hans Clevers (2002)
TCF: Lady Justice Casting the Final Verdict on the Outcome of Wnt Signalling, 383
J. Hsieh, Damian Yap, D. O’Connor, V. Fogal, L. Fallis, F. Chan, S. Zhong, Xin Lu (2002)
Novel Function of the Cyclin A Binding Site of E2F in Regulating p53-Induced Apoptosis in Response to DNA DamageMolecular and Cellular Biology, 22
Yingcai Wang, G. Blandino, D. Givol (1999)
Induced p21waf expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicinOncogene, 18
S. Daujat, S. Daujat, H. Neel, J. Piette (2001)
MDM2: life without p53.Trends in genetics : TIG, 17 8
Rdg Malcomson, M. Oren, AH Wyllie, D. Harrison (1995)
p53-independent death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs.British Journal of Cancer, 72
K. Satyamoorthy, Gang Li, B. Vaidya, D. Patel, M. Herlyn (2001)
Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and β-Catenin PathwaysCancer Research, 61
M. Kubbutat, K. Vousden (1997)
Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stabilityMolecular and Cellular Biology, 17
F. Su, M. Overholtzer, D. Besser, A. Levine (2002)
WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase.Genes & development, 16 1
X. Mariette, J. Sibilia, S. Roux, V. Meignin, A. Janin (2002)
A new defensive mechanism to prevent apoptosis in salivary ductal cells from patients with Sjögren's syndrome: over-expression of p53 and p21.Rheumatology, 41 1
A. Yang, M. Kaghad, D. Caput, F. McKeon (2002)
On the shoulders of giants: p63, p73 and the rise of p53.Trends in genetics : TIG, 18 2
K. Sugars, V. Budhram-Mahadeo, G. Packham, D. Latchman (2001)
A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.Nucleic acids research, 29 22
E. Flores, K. Tsai, D. Crowley, Shomit Sengupta, A. Yang, F. McKeon, T. Jacks (2002)
p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 416
D. Bulavin, O. Demidov, Shinichi Saito, P. Kauraniemi, C. Phillips, S. Amundson, C. Ambrosino, G. Sauter, A. Nebreda, C. Anderson, A. Kallioniemi, A. Fornace, E. Appella (2002)
Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activityNature Genetics, 31
X Mariette, J Sibilia, S Roux, V Meignin, A Janin (2002)
Rheumatology
C. Desbois-Mouthon, A. Cadoret, M. Eggelpoël, F. Bertrand, G. Cherqui, C. Perret, J. Capeau (2001)
Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.Oncogene, 20 2
Serge Fuchs, V. Adler, T. Buschmann, Z. Yin, Xiangwei Wu, S. Jones, Z. Ronai (1998)
JNK targets p53 ubiquitination and degradation in nonstressed cells.Genes & development, 12 17
R. Ludwig, S. Bates, K. Vousden (1996)
Differential activation of target cellular promoters by p53 mutants with impaired apoptotic functionMolecular and Cellular Biology, 16
A. Mirza, Marnie McGuirk, Tish Hockenberry, Qun Wu, H. Ashar, Stuart Black, S. Wen, Luquan Wang, P. Kirschmeier, W. Bishop, L. Nielsen, C. Pickett, Suxing Liu (2002)
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathwayOncogene, 21
C. Venot, M. Maratrat, C. Dureuil, Emmanuel Conseiller, L. Bracco, L. Debussche (1998)
The requirement for the p53 proline‐rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repressionThe EMBO Journal, 17
N. Bissonnette, D. Hunting (1998)
p21-induced cycle arrest in G1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockageOncogene, 16
H. Symonds, L. Krall, L. Remington, M. Sáenz-Robles, S. Lowe, T. Jacks, T. Dyke (1994)
p53-Dependent apoptosis suppresses tumor growth and progression in vivoCell, 78
J. Momand, Hsiao-Huei Wu, G. Dasgupta (2000)
MDM2--master regulator of the p53 tumor suppressor protein.Gene, 242 1-2
E. Sadot, B. Geiger, M. Oren, A. Ben-Ze'ev (2001)
Down-Regulation of β-Catenin by Activated p53Molecular and Cellular Biology, 21
Yan Wang, C. Prives (1995)
Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinasesNature, 376
N. Chehab, A. Malikzay, M. Appel, T. Halazonetis (2000)
Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.Genes & development, 14 3
Y. Shen, T. Shenk (1994)
Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein.Proceedings of the National Academy of Sciences of the United States of America, 91 19
M. Patturajan, S. Nomoto, M. Sommer, A. Fomenkov, K. Hibi, R. Zangen, N. Poliak, J. Califano, B. Trink, E. Ratovitski, D. Sidransky (2002)
DeltaNp63 induces beta-catenin nuclear accumulation and signaling.Cancer cell, 1 4
H. Ding, D. Fisher (2001)
p53, Caspase 8, and Regulation of Apoptosis After Ionizing RadiationJournal of Pediatric Hematology/Oncology, 23
L. Rössig, C. Badorff, Y. Holzmann, A. Zeiher, S. Dimmeler (2002)
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation*The Journal of Biological Chemistry, 277
M. Patturajan, S. Nomoto, M. Sommer, A. Fomenkov, K. Hibi, R. Zangen, N. Poliak, J. Califano, B. Trink, E. Ratovitski, D. Sidransky (2002)
ΔNp63 induces β-catenin nuclear accumulation and signalingCancer Cell, 1
M. Moroni, E. Hickman, E. Denchi, G. Caprara, E. Colli, F. Cecconi, H. Müller, K. Helin (2001)
Apaf-1 is a transcriptional target for E2F and p53Nature Cell Biology, 3
F. Bunz, P. Hwang, C. Torrance, C. Torrance, T. Waldman, Yonggang Zhang, L. Dillehay, Jerry Williams, C. Lengauer, K. Kinzler, B. Vogelstein (1999)
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.The Journal of clinical investigation, 104 3
P. Lambert, F. Kashanchi, M. Radonovich, R. Shiekhattar, J. Brady (1998)
Phosphorylation of p53 Serine 15 Increases Interaction with CBP*The Journal of Biological Chemistry, 273
M. Pap, G. Cooper (1998)
Role of Glycogen Synthase Kinase-3 in the Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway*The Journal of Biological Chemistry, 273
K. Polyak, T. Waldman, T. He, K. Kinzler, B. Vogelstein (1996)
Genetic determinants of p53-induced apoptosis and growth arrest.Genes & development, 10 15
J. Bargonetti, J. Manfredi (2002)
Multiple roles of the tumor suppressor p53Current Opinion in Oncology, 14
D. Woods, K. Vousden (2001)
Regulation of p53 function.Experimental cell research, 264 1
J. Weitzman, L. Fiette, K. Matsuo, M. Yaniv (2000)
JunD protects cells from p53-dependent senescence and apoptosis.Molecular cell, 6 5
V. Tergaonkar, M. Pando, O. Vafa, G. Wahl, I. Verma (2002)
p53 stabilization is decreased upon NFκB activationCancer Cell, 1
I. Roninson (2002)
Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts.Cancer letters, 179 1
Y. Li, D. Dowbenko, L. Lasky (2002)
AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell Survival*The Journal of Biological Chemistry, 277
C. Weston, R. Davis (2001)
Signal transduction: signaling specificity- a complex affair.Science, 292 5526
M Bennett, K Macdonald, SW Chan, JP Luzio, R Simari, P Weissberg (1998)
Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis [see comments]Science, 282
William Hoffman, S. Biade, J. Zilfou, Jiandong Chen, M. Murphy (2002)
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53*The Journal of Biological Chemistry, 277
B. Vogelstein, D. Lane, A. Levine (2000)
Surfing the p53 networkNature, 408
S. Matsuzawa, John Reed (2001)
Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.Molecular cell, 7 5
D. Ginsberg, F. Mechta, M. Yaniv, M. Oren (1991)
Wild-type p53 can down-modulate the activity of various promoters.Proceedings of the National Academy of Sciences of the United States of America, 88 22
Melissa Jack, Richard Woo, A. Hirao, Alison Cheung, T. Mak, Patrick Lee (2002)
Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic responseProceedings of the National Academy of Sciences of the United States of America, 99
Yardena Samuels-Lev, D. O’Connor, D. Bergamaschi, G. Trigiante, J. Hsieh, S. Zhong, Isabelle Campargue, L. Naumovski, T. Crook, Xin Lu (2001)
ASPP proteins specifically stimulate the apoptotic function of p53.Molecular cell, 8 4
J. Russell, John Powers, R. Rounbehler, P. Rogers, C. Conti, David Johnson (2002)
ARF Differentially Modulates Apoptosis Induced by E2F1 and MycMolecular and Cellular Biology, 22
Ting Wang, Takahiko Kobayashi, R. Takimoto, Alec Denes, E. Snyder, W. El-Deiry, R. Brachmann (2001)
hADA3 is required for p53 activityThe EMBO Journal, 20
E. Shaulian, M. Schreiber, F. Piu, M. Beeche, E. Wagner, M. Karin (2000)
The Mammalian UV Response c-Jun Induction Is Required for Exit from p53-Imposed Growth ArrestCell, 103
Yan Shen, Eileen White (2001)
p53-dependent apoptosis pathways.Advances in cancer research, 82
S. Deb (2002)
Function and dysfunction of the human oncoprotein MDM2.Frontiers in bioscience : a journal and virtual library, 7
C. Desbois-Mouthon, A. Cadoret, M. Eggelpoël, F. Bertrand, G. Cherqui, C. Perret, J. Capeau (2001)
Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activationOncogene, 20
R. Frade, M. Balbo, M. Barel (2000)
RB18A, whose gene is localized on chromosome 17q12-q21.1, regulates in vivo p53 transactivating activity.Cancer research, 60 23
D. Alarcon-Vargas, Z. Ronai (2002)
p53-Mdm2--the affair that never ends.Carcinogenesis, 23 4
Jun Liu, J. Stevens, C. Rote, H. Yost, Yaoxiong Hu, K. Neufeld, Raymond White, N. Matsunami (2001)
Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein.Molecular cell, 7 5
S. Fukumoto, C. Hsieh, K. Maemura, M. Layne, S. yet, Kyung-Han Lee, T. Matsui, A. Rosenzweig, W. Taylor, J. Rubin, M. Perrella, Mu-En Lee (2001)
Akt Participation in the Wnt Signaling Pathway through Dishevelled*The Journal of Biological Chemistry, 276
A. Damalas, Sharon Kahan, M. Shtutman, A. Ben-Ze'ev, M. Oren (2001)
Deregulated β‐catenin induces a p53‐ and ARF‐dependent growth arrest and cooperates with Ras in transformationThe EMBO Journal, 20
M. Oren, V. Rotter (1999)
Introduction: p53 – the first twenty yearsCellular and Molecular Life Sciences CMLS, 55
Devorah Matas, A. Sigal, P. Stambolsky, M. Milyavsky, L. Weisz, D. Schwartz, N. Goldfinger, V. Rotter (2001)
Integrity of the N‐terminal transcription domain of p53 is required for mutant p53 interference with drug‐induced apoptosisThe EMBO Journal, 20
M. Ashcroft, R. Ludwig, DB Woods, TD Copeland, HO Weber, EJ MacRae, K. Vousden (2002)
Phosphorylation of HDM2 by AktOncogene, 21
Gad Asher, J. Lotem, R. Kama, L. Sachs, Y. Shaul (2002)
NQO1 stabilizes p53 through a distinct pathwayProceedings of the National Academy of Sciences of the United States of America, 99
Piyajit Watcharasit, G. Bijur, J. Zmijewski, Ling Song, Anna Zmijewska, Xinbin Chen, G. Johnson, R. Jope (2002)
Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damageProceedings of the National Academy of Sciences of the United States of America, 99
M. Schuler, E. Bossy‐Wetzel, J. Goldstein, Patrick Fitzgerald, D. Green (2000)
p53 Induces Apoptosis by Caspase Activation through Mitochondrial Cytochrome c Release*The Journal of Biological Chemistry, 275
A. Contente, A. Dittmer, M. Koch, J. Roth, M. Dobbelstein (2002)
A polymorphic microsatellite that mediates induction of PIG3 by p53Nature Genetics, 30
E. Hickman, M. Moroni, K. Helin (2002)
The role of p53 and pRB in apoptosis and cancer.Current opinion in genetics & development, 12 1
S. Maheswaran, C. Englert, P. Bennett, G. Heinrich, D. Haber (1995)
The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.Genes & development, 9 17
M. Esteller, S. Tórtola, Minoru Toyota, G. Capellá, M. Peinado, S. Baylin, James Herman (2000)
Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.Cancer research, 60 1
R. Sears, J. Nevins (2002)
Signaling Networks That Link Cell Proliferation and Cell Fate*The Journal of Biological Chemistry, 277
P. Polakis (2000)
Wnt signaling and cancer.Genes & development, 14 15
A. Fazeli, R. Steen, S. Dickinson, D. Bautista, W. Dietrich, R. Bronson, R. Bresalier, E. Lander, J. Costa, R. Weinberg (1997)
Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas.Proceedings of the National Academy of Sciences of the United States of America, 94 19
Manju Sharma, W. Chuang, Zijie Sun (2002)
Phosphatidylinositol 3-kinase/Akt stimulates androgen pathway through GSK3beta inhibition and nuclear beta-catenin accumulation.The Journal of biological chemistry, 277 34
P. Sabbatini, S. Chiou, L. Rao, E. White (1995)
Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K proteinMolecular and Cellular Biology, 15
N. Baptiste, P. Friedlander, Xinbin Chen, C. Prives (2002)
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cellsOncogene, 21
M. Ashcroft, Y. Taya, K. Vousden (2000)
Stress Signals Utilize Multiple Pathways To Stabilize p53Molecular and Cellular Biology, 20
K. Ryan, M. Ernst, N. Rice, K. Vousden (2000)
Role of NF-κB in p53-mediated programmed cell deathNature, 404
Harry Rogoff, M. Pickering, M. Debatis, S. Jones, T. Kowalik (2002)
E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and ApoptosisMolecular and Cellular Biology, 22
Y. Haupt, S. Rowan, E. Shaulian, K. Vousden, M. Oren (1995)
Induction of apoptosis in HeLa cells by trans-activation-deficient p53.Genes & development, 9 17
K. Ryan, M. Ernst, N. Rice, K. Vousden (2000)
Role of NF-kappaB in p53-mediated programmed cell death.Nature, 404 6780
V. Stambolic, D. MacPherson, D. Sas, Yunping Lin, B. Snow, Y. Jang, S. Benchimol, T. Mak (2001)
Regulation of PTEN transcription by p53.Molecular cell, 8 2
D. Tolbert, Xiangdong Lu, C. Yin, M. Tantama, T. Dyke (2002)
p19ARF Is Dispensable for Oncogenic Stress-Induced p53-Mediated Apoptosis and Tumor Suppression In VivoMolecular and Cellular Biology, 22
D. Brazil, B. Hemmings (2001)
Ten years of protein kinase B signalling: a hard Akt to follow.Trends in biochemical sciences, 26 11
M. Peifer, P. Polakis (2000)
Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus.Science, 287 5458
F. Vikhanskaya, M. Broggini (1995)
Decreased cytotoxic effects of doxorubicin in a human ovarian cancer‐cell line expressing wild‐type p53 and WAF1/CIP1 genesInternational Journal of Cancer, 61
U. Moll, A. Zaika (2001)
Nuclear and mitochondrial apoptotic pathways of p53FEBS Letters, 493
R. Meng, E. McDonald, M. Sheikh, A. Fornace, W. El-Deiry (2000)
The TRAIL decoy receptor TRUNDD (DcR2, TRAIL-R4) is induced by adenovirus-p53 overexpression and can delay TRAIL-, p53-, and KILLER/DR5-dependent colon cancer apoptosis.Molecular therapy : the journal of the American Society of Gene Therapy, 1 2
Bhuvanesh Singh, P. Reddy, A. Goberdhan, C. Walsh, S. Dao, Ivan Ngai, T. Chou, P. O-Charoenrat, A. Levine, P. Rao, Archontoula Stoffel (2002)
p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas.Genes & development, 16 8
T. Maclachlan, R. Takimoto, W. El-Deiry (2002)
BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair TargetsMolecular and Cellular Biology, 22
K. Satyamoorthy, G. Li, B. Vaidya, D. Patel, M. Herlyn (2001)
Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways.Cancer research, 61 19
D. Michael, M. Oren (2002)
The p53 and Mdm2 families in cancer.Current opinion in genetics & development, 12 1
A. Damalas, A. Ben-Ze'ev, I. Simcha, M. Shtutman, J. Leal, J. Zhurinsky, B. Geiger, M. Oren (1999)
Excess β‐catenin promotes accumulation of transcriptionally active p53The EMBO Journal, 18
F. Bunz, A. Dutriaux, C. Lengauer, T. Waldman, Shibin Zhou, J. Brown, J. Sedivy, K. Kinzler, B. Vogelstein (1998)
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.Science, 282 5393
Binhua Zhou, Y. Liao, W. Xia, Y. Zou, B. Spohn, M. Hung (2001)
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylationNature Cell Biology, 3
C. Caelles, A. Helmberg, M. Karin (1994)
p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genesNature, 370
J. Zilfou, William Hoffman, Michael Sank, D. George, M. Murphy (2001)
The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated DegradationMolecular and Cellular Biology, 21
V. Tergaonkar, M. Pando, O. Vafa, G. Wahl, I. Verma (2002)
p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy.Cancer cell, 1 5
M. Lohrum, K. Scheidtmann (1996)
Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.Oncogene, 13 12
R. Benetti, G. Sal, M. Monte, G. Paroni, C. Brancolini, C. Schneider (2001)
The death substrate Gas2 binds m‐calpain and increases susceptibility to p53‐dependent apoptosisThe EMBO Journal, 20
P. Lassus, C. Bertrand, O. Zugasti, J. Chambón, T. Soussi, D. Mathieu-Mahul, U. Hibner (1999)
Anti-apoptotic activity of p53 maps to the COOH-terminal domain and is retained in a highly oncogenic natural mutantOncogene, 18
M. Gorospe, C. Cirielli, X. Wang, P. Seth, M. Capogrossi, N. Holbrook (1997)
p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells.Oncogene, 14 8
Scott Lowe (1999)
Activation of p53 by oncogenes.Endocrine-related cancer, 6 1
M. Monick, A. Carter, P. Robeff, D. Flaherty, M. Peterson, G. Hunninghake (2001)
Lipopolysaccharide Activates Akt in Human Alveolar Macrophages Resulting in Nuclear Accumulation and Transcriptional Activity of β-Catenin1The Journal of Immunology, 166
C. Sherr, J. Weber (2000)
The ARF/p53 pathway.Current opinion in genetics & development, 10 1
S. Haldar, M. Negrini, M. Monne, S. Sabbioni, C. Croce (1994)
Down-regulation of bcl-2 by p53 in breast cancer cells.Cancer research, 54 8
S. Persad, Armelle A.Troussard, T. McPhee, D. Mulholland, S. Dedhar (2001)
Tumor Suppressor Pten Inhibits Nuclear Accumulation of β-Catenin and T Cell/Lymphoid Enhancer Factor 1–Mediated Transcriptional ActivationThe Journal of Cell Biology, 153
Xiangwei Wu, A. Levine (1994)
p53 and E2F-1 cooperate to mediate apoptosis.Proceedings of the National Academy of Sciences of the United States of America, 91 9
Manju Sharma, W. Chuang, Zijie Sun (2002)
Phosphatidylinositol 3-Kinase/Akt Stimulates Androgen Pathway through GSK3β Inhibition and Nuclear β-Catenin Accumulation*The Journal of Biological Chemistry, 277
B. McKay, C. Becerril, M. Ljungman (2001)
P53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblastsOncogene, 20
Y. Ogawara, Shohei Kishishita, T. Obata, Yuko Isazawa, Toshiaki Suzuki, Keiji Tanaka, Norihisa Masuyama, Y. Gotoh (2002)
Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53*The Journal of Biological Chemistry, 277
K. Regula, L. Kirshenbaum (2001)
p53 activates the mitochondrial death pathway and apoptosis of ventricular myocytes independent of de novo gene transcription.Journal of molecular and cellular cardiology, 33 8
L. Mayo, D. Donner (2001)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleusProceedings of the National Academy of Sciences of the United States of America, 98
Noriko Shikama, Chang-Woo Lee, Stephen France, Laurent Delavaine, Jonathan Lyon, Marija Krstic-Demonacos, N. Thangue (1999)
A novel cofactor for p300 that regulates the p53 response.Molecular cell, 4 3
A. Wagner, J. Kokontis, N. Hay (1994)
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.Genes & development, 8 23
T. Miyashita, M. Harigai, M. Hanada, John Reed (1994)
Identification of a p53-dependent negative response element in the bcl-2 gene.Cancer research, 54 12
A. Costanzo, P. Merlo, N. Pediconi, M. Fulco, V. Sartorelli, P. Cole, G. Fontemaggi, M. Fanciulli, L. Schiltz, G. Blandino, C. Balsano, M. Levrero (2002)
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.Molecular cell, 9 1
The p53 tumor-suppressor plays a critical role in the prevention of human cancer. In the absence of cellular stress, the p53 protein is maintained at low steady-state levels and exerts very little, if any, effect on cell fate. However, in response to various types of stress, p53 becomes activated; this is reflected in elevated protein levels, as well as augmented biochemical capabilities. As a consequence of p53 activation, cells can undergo marked phenotypic changes, ranging from increased DNA repair to senescence and apoptosis. This review deals with the mechanisms that underlie the apoptotic activities of p53, as well as the complex interactions between p53 and central regulatory signaling networks. In p53-mediated apoptosis, the major role is played by the ability of p53 to transactivate specific target genes. The choice of particular subsets of target genes, dictated by covalent p53 modifications and protein–protein interactions, can make the difference between life and apoptotic death of a cell. In addition, transcriptional repression of antiapoptotic genes, as well as transcription-independent activities of p53, can also contribute to the apoptotic effects of p53. Regarding the crosstalk between p53 and signaling networks, this review focuses on the interplay between p53 and two pivotal regulatory proteins: β-catenin and Akt/PKB. Both proteins can regulate p53 as well as be regulated by it. In addition, p53 interacts with the GSK-3β kinase, which serves as a link between Akt and β-catenin. This review discusses how the functional balance between these different interactions might dictate the likelihood of a given cell to become cancerous or be eliminated from the replicative pool, resulting in suppression of cancer.
Cell Death & Differentiation – Springer Journals
Published: Apr 28, 2003
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.